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As the most common cause of sexually transmitted disease in women, chlamydial infections can lead to pelvic
inflammatory disease, infertility, and ectopic pregnancy. To better understand the role played by sex hormones
in modulating the immune response of the genital tract to microbial infections, we have developed a rat model
to study Chlamydia trachomatis infection. Inbred female Lewis rats were primed with progesterone and inoc-
ulated by intrauterine instillation of C. trachomatis (mouse pneumonitis strain MoPn) into each uterine horn.
When infected animals were examined for the presence of chlamydial antigens 14 days postinfection, both the
uterus and vagina were found to be positive compared to those of saline-treated animals, which did not show
specific staining. The involvement of local and systemic immune systems following chlamydial infection was
determined by analyzing major histocompatibility complex (MHC) class II expression in the reproductive tract
and lymphocyte proliferation in response to mitogenic and chlamydia-specific stimulation of cells from the
spleen and lymph nodes (LN) draining the reproductive tract. Enhanced proliferation was observed in LN follow-
ing mitogenic but not antigenic (MOMP [major outer membrane protein]) stimulation. In contrast, spleen cell
proliferation was lower in chlamydia-infected rats than in saline-treated controls. MHC class II expression, an
indicator of inflammatory responses, was upregulated in the uterus, on glandular epithelial cells, and adjacent
to glands in response to chlamydial infection. In other experiments, when rats were infected at estrus and diestrus
without prior progesterone priming, chlamydial inclusions were not detected in either the uterus or vagina. How-
ever, enhanced lymphocyte proliferation was observed in response to mitogenic and MOMP stimulation in the
reproductive tract-draining LN from estrous and diestrous animals. These findings indicate that under ap-
propriate endocrine conditions, the rat uterus is susceptible to C. trachomatis infection and that immune
responses to this pathogen can be detected locally and systemically. Further, they suggest that clearance of the
infection from the reproductive tract involves immune cells from the LN draining the reproductive tract.
Chlamydia trachomatis is an obligate intracellular gram-neg-
ative bacteria that is known to infect the genital tract and
ocular epithelium. Disease caused by this organism can range
from acute self-limiting infection to chronic inflammatory con-
ditions, which can result in pelvic inflammatory disease, infer-
tility, and ectopic pregnancy (12). Chlamydial infection of the
urogenital tract is currently the leading cause of sexually trans-
mitted disease in adolescents and women in the United States
and Europe (11). Despite the recognition of chlamydial infec-
tion as a major public health concern, immune responses to
human chlamydial infection are not well understood. Both
T-cell-mediated and humoral responses are known to be in-
volved in resolution of chlamydial infection. However, protec-
tive immunity developed as a result of chlamydial infection is
transient, and reinfections are common (12).
Animal models to study chlamydial infections have been
developed in the mouse, guinea pig, marmoset, and nonhuman
primate (13, 15). In mice, for example, inoculations of chla-
mydiae via intravaginal and intrauterine routes are known to
cause cervicitis or salpingitis, respectively (17, 18). In this spe-
cies, intravaginal infection with human serovars of chlamydiae
was dependent on pretreatment with progesterone (18). In the
guinea pig, however, pretreatment with estradiol markedly en-
hanced the course of infection with guinea pig inclusion con-
junctivitis (16). In all cases, endocrine balance at the time of
exposure to chlamydiae appeared to play a crucial role for host
susceptibility.
Previous work from our laboratory has demonstrated that
sex hormones regulate the mucosal immune response in the
female reproductive tract. Using the rat as a model system, we
and others have shown that stage of the estrous cycle and
treatment with sex hormones, specifically estradiol and proges-
terone, influence both the afferent and efferent arms of the
immune system (for a review see reference 19). For example,
antigen presentation, immunoglobulin A (IgA) transport, im-
mune cell traffic into the reproductive tract, and cytokine pro-
duction in the uterus and vagina have been shown to be under
hormonal control. The aims of the present study were (i) to
determine if infection could be successfully established in rats
following intrauterine exposure to chlamydiae with or without
progesterone treatment and (ii) to determine if immune re-
sponses occur locally and at sites distal to the reproductive
tract in response to chlamydial infection.
MATERIALS AND METHODS
General methods and inoculation. Adult female Lewis rats (Charles River
Breeding Laboratories, Kingston, N.Y.) weighing 150 to 200 g were maintained
under standard temperature-controlled conditions with 12-h intervals of light
and dark. Progesterone was purchased from Calbiochem (La Jolla, Calif.), sus-
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pended in saline by glass-glass homogenization, and administered by subcutane-
ous injection. Stages of the estrous cycle were determined by daily vaginal
smears. C. trachomatis (mouse pneumonitis nigg-II strain, MoPn) was purchased
from the American Type Culture Collection (catalog no. VR-123). Females were
administered 10 mg of progesterone 7 days before infection with 1 3 104 to 5 3
104 50% tissue culture infective doses (TCID50)/40 ml/uterus. A second 10-mg
progesterone injection was given on the day of infection. Control animals re-
ceived progesterone treatment followed by intrauterine instillation of sterile 0.15
M saline (40 ml). Animals at estrous and diestrous stages of the cycle received
intrauterine inoculations of 1 3 104 to 5 3 104 TCID50 of MoPn. Control animals
received saline instead of MoPn at the same stage of the estrous cycle. In all
studies, animals were sacrificed 14 days postinfection. For intrauterine instilla-
tion of MoPn, rats were anesthetized, a midventral incision was made, uteri were
exposed, and MoPn in saline or saline alone was injected with a 30-gauge needle
into the uterus at the oviductal end.
Immunohistochemical analysis. For immunohistochemical analysis, uteri and
vaginas were excised and rinsed in cold saline (0.9%) prior to processing with
acetone, methyl alcohol, and xylene as previously described (8). Briefly, 6- to
8-mm sections were cut with a microtome and placed on slides coated with 1.5%
bovine serum albumin. Sections were deparaffinized in xylene, rehydrated, and
washed in 0.01 M phosphate-buffered saline–bovine serum albumin (1 mg/ml).
Nonspecific binding was blocked by incubating sections with 1% rabbit serum for
20 min at room temperature. To detect chlamydial infection, sections were
stained with rabbit anti-C. trachomatis (Biodesign Int., Kennebunk, Maine) poly-
clonal antisera (1:200) for 60 min, rinsed, and incubated with goat anti-rabbit Ig
(1:200 dilution) for an additional 30 min. Antiserum from normal rabbits was
substituted for primary antibody at an equivalent concentration for control
staining. Avidin-biotin coupled to alkaline phosphatase (ABC Elite kit; Vector
Laboratories, Burlingame, Calif.) followed by Vector Red (alkaline phosphatase
substrate kit; Vector Laboratories) was used to reveal antigen localization. To
stain for major histocompatibility complex (MHC) class II antigens, a mouse
monoclonal antibody to rat Ia (OX-6) was used as the primary antibody, and the
second antibody was horse anti-mouse Ig coupled to biotin. Slides were coun-
terstained with methyl green, dehydrated in alcohol, and mounted in Permount
medium prior to microscopic examination.
LN and spleen cell proliferation. To measure lymph node (LN) and spleen cell
proliferation, para-aortic LN draining the genital tract and spleens were removed
aseptically from animals. Single-cell suspensions were prepared by teasing with
sterile forceps. Debris was allowed to settle for 2 min, and the supernatant
containing single cells was spun down at 500 3 g for 10 min. Spleen cells were
treated with NH4Cl solution for 10 min to lyse the erythrocytes as previously
described (14). Cells were washed three times with RPMI 1640 medium con-
taining 10% fetal bovine serum and plated in 96-well chambers at a concentra-
tion of 5 3 105 cells per well. A final concentration of 1 mg of concanavalin A
(ConA) per ml, 5 mg of phytohemagglutinin (PHA) per ml, 10 mg of lipopoly-
saccharide (LPS) per ml, or 1 and 5 mg of major outer membrane protein
(MOMP) per ml was added to each well. Proliferative responses were measured
by uptake of 1 mCi of [3H]thymidine per well for the last 24 h of a 3-day culture.
Results are reported as mean counts per minute 6 standard error of triplicate
cultures. Each experiment was repeated at least two times. Data were analyzed
by using Student’s t test.
RESULTS
Intrauterine chlamydial infection under the influence of
progesterone. Chlamydial infection is initiated when the infec-
tious form of C. trachomatis, the elementary body, attaches to
the lining of the genital tract and invades the epithelial cells.
Once internalized, the elementary body avoids phagolysosomal
fusion and differentiates into the reticulate body, which mul-
tiplies by binary fission inside the endophagosome, forming a
large inclusion body inside the epithelial cell. The presence of
inclusion bodies is a characteristic feature of chlamydial infec-
tion. In this study, uteri and vaginas from progesterone-treated
animals exposed to chlamydiae or saline were examined 14
days postinfection for the presence of chlamydial inclusions by
immunohistochemistry, using a polyclonal rabbit antibody to
chlamydial inclusions. As shown in Fig. 1A, positive staining
with antichlamydia antibody was observed in the uteri of ani-
mals which had received an intrauterine inoculum of MoPn.
Chlamydial inclusions were localized in glandular epithelial
cells in the uterus. Saline-injected control animals did not show
any positive staining (Fig. 1B). Among the total of 14 animals
infected with chlamydiae in the uterus, infection was also de-
tected in the vaginas of 5 animals. As seen in Fig. 1C, chla-
mydia-specific staining was observed in cervicovaginal epithelia
of infected animals. Infection was confined to localized areas
of the epithelium, as determined by positive staining for chla-
mydial antigen and not present throughout the epithelial lining
of the cervicovaginal tissue. No specific staining was detected
in saline controls (Fig. 1D). As a part of these studies, uteri and
vaginal tissues stained with a monoclonal antibody specific for
chlamydiae showed a staining pattern similar to that seen in
Fig. 1 with polyclonal sera (data not shown).
When immune markers for host inflammatory response
were analyzed following chlamydial infection, uteri from chla-
mydia-infected animals showed enhanced MHC class II (Ia)
expression compared to saline-treated animals, indicating that
chlamydial infection increases the number of Ia-positive cells
in uteri of infected rats. As seen in Fig. 2, Ia-positive staining
was observed in the glandular epithelium, although a few pos-
itive cells were seen adjacent to the glands as well as inter-
spersed in the stroma (Fig. 2A). In contrast, very few MHC
class II-positive cells were localized in the uteri of control
animals exposed to saline instead of chlamydia (Fig. 2B).
LN and spleen responses of progesterone-treated infected
rats to mitogens and MOMP. To examine whether immune
responses to chlamydial infection in progesterone-treated an-
imals extended beyond the reproductive tract, cells from the
LN draining the reproductive tract (para-aortic LN) and
spleen were cultured either alone or in the presence of known
mitogens or MOMP (a chlamydia-specific antigen) to measure
cell proliferation. As seen in Fig. 3A, LN cells from chlamyd-
ia-infected animals, in the absence of mitogenic stimulation,
showed proliferation two to threefold higher than that seen in
saline controls. In response to ConA and PHA, LN cells from
chlamydia-infected rats had a significantly higher proliferative
response than did LN cells from control animals. The chla-
mydia-specific response indicated by MOMP-induced prolifer-
ation was higher in progesterone-treated, chlamydia-infected
animals than in saline controls. In contrast, spleen cell prolif-
eration, in the absence of mitogens (control), was lower in
infected animals than in saline controls (Fig. 3B). In response
to mitogen (PHA) and MOMP, proliferation of spleen cells
from chlamydia-infected animals was significantly lower than
that seen in saline-treated animals (Fig. 3B) (the results are
representative of four separate experiments).
Intrauterine chlamydial infection in animals at normal stages
of the estrous cycle. In an attempt to determine if progesterone
pretreatment is essential for successful chlamydial infection,
normal rats at specific stages of the estrous cycle were infected
without prior progesterone treatment. Female rats were in-
fected with 1 3 104 to 5 3 104 TCID50 of MoPn/uterine horn
at either the estrous or diestrous stage of the reproductive
cycle. Control animals at the same stage of the cycle received
40 ml of saline/uterus. Estrous and diestrous stages were se-
lected because estradiol and progesterone, respectively, are
known to be the predominant hormones in the circulation at
these stages of the reproductive cycle. Animals were sacrificed
14 days postinfection, and uteri and vaginas were examined for
chlamydial inclusions, using a polyclonal antichlamydia anti-
body. As seen in Fig. 4, no positive staining could be detected
in the uteri of chlamydia-infected animals at either estrus or
diestrus. Irrespective of whether animals were infected at es-
trus or diestrus, vaginas were also negative for any signs of
infection (data not shown).
To examine whether lymph node proliferation was influ-
enced by uterine chlamydia infection in rats infected at estrus
or diestrus, para-aortic lymph nodes were cultured in the pres-
ence or absence of mitogens. As seen in Fig. 5, in the absence
of mitogens, LN cells from chlamydia-infected animals at es-
trus and diestrus had levels of proliferation significantly higher
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(four- to sixfold) than that seen with LN cells from saline-
treated animals. Shown in Fig. 5A and B are the responses of
LN cells to mitogenic stimulation. Compared to estrous cycle-
matched controls, LN cells from chlamydia-infected animals
had significantly enhanced proliferation at estrus (PHA and
LPS) and diestrus (ConA and LPS). When chlamydia-specific
proliferation was examined following in vitro stimulation with
MOMP (1 and 5 mg), significantly enhanced proliferation was
seen in LN cells from rats infected with chlamydia at estrus
compared to saline controls (Fig. 5C). LN from animals in-
fected at diestrus also had higher proliferation compared to
their saline controls, although this difference was not found
to be statistically significant. These results indicate that in-
trauterine exposure of intact animals to chlamydiae results
in enhanced LN proliferation in response to mitogens and
chlamydia-specific antigen 14 days postinoculation under con-
ditions in which no evidence of chlamydial infection was de-
tected in the uterus or vagina.
Time course of immune response to chlamydial infection
following intrauterine exposure. In an attempt to understand
the kinetics of infection and immune response to intrauterine
chlamydia instillation, we performed a time course study where
rats were infected with MoPn (i) at estrus, (ii) at diestrus, and
(iii) following progesterone pretreatment and sacrificed 3, 7, or
14 days postinfection. Shown in Fig. 6 are LN proliferation
responses at the earliest time point (day 3) at which LN pro-
liferation was observed in all three experimental groups, indi-
cating an early immune response to the presence of chlamyd-
iae. LN proliferation on day 3 varied with hormonal balance.
Enhanced mitogenic responses were seen with LN cells from
all three experimental groups. Higher LN proliferation in re-
sponse to MOMP was observed in animals infected at estrus
and diestrus than in progesterone-pretreated animals. In the
absence of any stimulation, LN from progesterone-pretreated
animals had lower proliferation (Fig. 6A). On the other hand,
significantly higher proliferation was seen in LN cells from
animals infected at both estrus (twofold) and diestrus (four-
fold) in the absence of any other stimulation (Fig. 6B and C).
These results indicate that LN immune responses of intact rats
(estrus and diestrus) are more pronounced in response to
infection than those of progesterone-treated rats.
In other studies (not shown), infection, determined by the
presence of inclusion bodies, was not observed in intact ani-
mals infected during the estrous cycle (estrus and diestrus) at
any of the time points analyzed. In progesterone-pretreated
animals, no infection was observed in the uterus on day 3, uteri
of four of eight animals were found sporadically positive on
day 7 around the glandular epithelium, and uteri of all animals
were positive on day 14 (data not shown).
FIG. 1. Localization of chlamydial antigen by immunochemistry in uteri and vaginas of progesterone-treated rats inoculated with chlamydiae. Polyclonal antichla-
mydia antibody (1:200) was used to detect chlamydia-specific staining. Positive staining is seen in the epithelium of both uterus (A) and vagina (C). Controls shown
are uterus (B) and vagina (D) from saline-treated animals stained with the same antibody. s, stroma; g, gland; lu, lumen; e, epithelium. Bars, 80 mm.
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DISCUSSION
Collectively these data show that the rat can be used to study
infectivity of the female reproductive tract and immune re-
sponses to C. trachomatis. Upon progesterone treatment fol-
lowed by MoPn exposure, chlamydial inclusions were found in
the epithelial cells of the uteri and vaginas of infected rats 14
days postinfection. This study indicates that under appropriate
hormonal conditions, C. trachomatis is able to establish a pro-
longed, low-grade infection in the rat uterus which may de-
scend into the vagina. When non-progesterone-treated intact
rats were exposed to C. trachomatis at estrous and diestrous
stages of the reproductive cycle, chlamydial inclusions were not
detected in either the uterus or vagina 14 days after infec-
tion. One likely explanation for this is that in these animals,
chlamydial infection was cleared within 14 days, indicating
an acute, self-limiting infection. That the immune system
responded to chlamydial challenge is supported by the obser-
vation that lymph node cells were still in a state of activation in
animals infected at both estrus and diestrus, despite the ab-
sence of chlamydial inclusions in the reproductive tract tissue.
Enhanced proliferation of LN cells from animals infected at
estrus and diestrus was seen, both in response to nonspecific
mitogenic stimulation and following in vitro challenge with the
chlamydia-specific antigen MOMP. These results indicate that
the infected animals exhibited a specific immune response to
chlamydial infections.
A comparison of proliferative responses on day 3 following
infection of rats pretreated with progesterone as well as
those infected at estrus and diestrus indicated that immune
responses to chlamydia vary with endocrine balance at the time
of infection. Progesterone-treated animals did not show any
chlamydia-specific responses and modestly enhanced mitogen-
ic stimulation. In contrast, animals infected at estrus and
diestrus, without prior progesterone treatment, had dramati-
cally enhanced LN cell proliferation responses in the absence
of any stimulation, following mitogenic stimulation, and in
response to chlamydia-specific antigenic challenge. These re-
sults indicate that early immune responses may play an impor-
tant role in the clearance of infection in this animal model.
Unlike exposure to other intracellular pathogens such as
Mycobacteria avium and Toxoplasma gondii (5, 20), exposure to
C. trachomatis does not appear to suppress the immune system
in these studies. This was indicated by the enhanced LN cell
proliferation observed in progesterone-treated rats following
infection, as well as the four- to sixfold-higher proliferation
observed in the LN of intact rats exposed to chlamydiae at
estrus and diestrus. Unexpectedly, we found that the mitogenic
response of spleen cells was suppressed in MoPn-infected an-
imals coincident with enhanced proliferation in local draining
LN. In other studies, we have found that gamma interferon
placed in the uteri of rats increased spleen cell mitogenic
responses (14). Also in response to gamma interferon depos-
ited in the uterus, there was an infiltration of polymorphonu-
clear cells and intraepithelial lymphocytes into the uterine tis-
sue. When considered in context with the present studies, these
FIG. 2. MHC class II-positive cells in uteri of progesterone-treated rats in-
oculated with chlamydiae (A) and saline (B). Class II expression is upregulated
in the uteri of chlamydia-treated animals compared to saline-treated rats. lu,
lumen. Bars, 80 mm.
FIG. 3. LN (A) and spleen (B) cell proliferation on day 14 in response to
mitogens and MOMP in progesterone-treated, control (saline-inoculated), and
chlamydia-infected animals. Three to five animals were used for each treatment
group. Results shown are representative of four separate experiments. Experi-
mental groups consist of LN or spleen cells incubated in the presence of control
(medium alone) (bar 1), ConA (bar 2), PHA (bar 3), LPS (bar 4), and MOMP
at 1 (bar 5), 5 (bar 6), and 10 (bar 7) mg/ml. p, P , 0.05.
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findings suggest that immune cells may migrate from the
spleen into the local LN in response to the infection in the
reproductive tract. Whether chlamydial infection leads to en-
hanced leukocytic traffic into the reproductive tract directly
from the spleen or via the LN remains to be determined.
As a part of this study, we observed a marked upregulation
of MHC class II expression in the uteri of infected animals
compared to that seen in saline controls, indicating a host
inflammatory response to chlamydial infection. In other stud-
ies, expression of MHC class II antigens has been observed in
the rat reproductive tract during the estrous cycle (6, 7, 9).
Levels of class II antigens were decreased in the uterus at
diestrus and following administration of progesterone along
with estradiol in ovariectomized animals. The results of this
study suggest that chlamydial infection overrides the effect of
progesterone in the uteri of infected animals. This may have
important implications in light of a recent hypothesis that
chlamydiae can lead to chronic inflammation in the uterus,
which may lead to embryo loss at the time of implantation (11).
Chronic elevation of class II antigen expression following chla-
mydial infection may cause recurrent abortions (1, 4). This may
be another possible cause of infertility in women suffering from
chronic chlamydial infection beyond the known pathologic se-
quelae including cervicitis and salpingitis.
Others have shown that sex hormones and their analogs
influence susceptibility to a variety of infections in the female
reproductive tract. For example, the incidence of vaginal can-
didiasis increases with the use of oral contraceptives (3). In
animal models, progesterone increases the mortality rate of
mice infected intravaginally with herpes simplex virus type 2
(2). In contrast, mice are more susceptible to genital infection
with Neisseria gonorrhoeae at proestrus, when estrogen levels
are highest (10). Similarly, estradiol treatment prior to chla-
mydial infection increases susceptibility to infection in female
guinea pigs (16). In contrast, others have shown that mice are
readily infected only after treatment with progesterone (18).
Our studies indicate that progesterone pretreatment is re-
quired to establish persistent uterine infection in rats when the
reproductive tract is exposed to low doses of chlamydiae. Why
progesterone pretreatment increases susceptibility to local in-
fection needs to be investigated. One possibility is that proges-
terone treatment interrupts the normal reproductive cyclicity,
FIG. 4. Localization of chlamydial antigen by immunochemistry in uteri of
rats inoculated with chlamydiae at estrus (A) or diestrus (B). No positive staining
could be detected in the uterus at either stage with a chlamydia-specific poly-
clonal antibody. Bars, 80 mm.
FIG. 5. (A and B) LN proliferation on day 14 in response to mitogens in
animals treated with chlamydiae at estrus (A) and diestrus (B). (C) MOMP-
specific proliferation in rats exposed to saline or chlamydiae at estrus or diestrus.
Three to five animals were used for each treatment group. Results shown are
representative of two separate experiments. p, P , 0.05.
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which may enhance the attachment of chlamydiae and estab-
lishment of infection in uterine epithelial cells. It is also pos-
sible that progesterone causes immunosuppression, decreasing
innate immunity to chlamydial infection. However, normal mi-
togenic responses of spleen and LN cells were observed in
progesterone-treated females exposed to MoPn or saline. Pre-
vious studies by us and others have shown that progesterone
may reverse immunity-enhancing effects of estradiol in the
reproductive tract, on polymeric immunoglobulin receptor lev-
els, on antigen presentation, and on the number of immune
cells present in the uterus (19).
In conclusion, in addition to identifying a new animal model,
our studies indicate that endocrine balance influences local
immune responses which may result in either enhanced or
compromised immune protection. The rat uterus may be a
particularly useful model for defining immune responses to
reproductive tract infections in humans because of the close
functional similarities between the reproductive tracts of the
two species. Future studies with this rat model should provide
insight into the role of ovarian hormones in regulating the
immune response to chlamydial infections in the genital tract.
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FIG. 6. LN proliferation on day 3 in response to mitogens and MOMP in
animals infected with chlamydiae following progesterone pretreatment (A), at
estrus (B), and at diestrus (C). Three to five animals were used for each treat-
ment group. Results shown are representative of two separate experiments.
Experimental groups consist of LN cells incubated in the presence of control
(medium alone) (bar 1), ConA (bar 2), PHA (bar 3), LPS (bar 4), and MOMP
at 1 (bar 5) and 5 (bar 6) mg/ml. p, P , 0.05.
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